Seminars in Oncology
Volume 33, Supplement 10 , Pages S8-S14, October 2006

Bevacizumab in Combination With Chemotherapy: First-Line Treatment of Patients With Metastatic Colorectal Cancer

  • Howard S. Hochster

      Affiliations

    • Dr Hochster is a consultant to Sanofi-Aventis, Genentech, and OSI Pharmaceuticals.
    • Corresponding Author InformationAddress reprint requests to Howard S. Hochster, MD, Department of Medicine, New York University Cancer Institute, 160 East 34th St, New York, NY 10016, USA.

Department of Medicine, New York University Cancer Institute, New York, NY.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(06)00316-2

doi:10.1053/j.seminoncol.2006.08.005

Seminars in Oncology
Volume 33, Supplement 10 , Pages S8-S14, October 2006

Article Tools

* Image Usage & Resolution